Last reviewed · How we verify
NCT07060222
Intestinal Preparation in Colonoscopy: Lactulose vs Sodium Phosphate.
Phase 4 trial testing Bowel preparation before colonoscopy: Lactulose. in Bowel Preparation for Colonoscopy in 300 participants. Not yet recruiting.
30 November 2025
Quick facts
| Lead sponsor | Hospital Civil de Guadalajara |
|---|---|
| Phase | Phase 4 |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | screening |
| Enrollment | 300 |
| Start date | 20 July 2025 |
| Primary completion | 30 November 2025 |
| Estimated completion | 31 December 2025 |
| Sites | 4 locations across Panama, Mexico |
Drugs / interventions tested
- Bowel preparation before colonoscopy: Lactulose.
- Bowel preparation before colonoscopy: Sodium phosphate.
Conditions studied
- Bowel Preparation for Colonoscopy — all drugs for Bowel Preparation for Colonoscopy →
Sponsor
Hospital Civil de Guadalajara
Who can join
18 and older, any sex, with Bowel Preparation for Colonoscopy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To compare intestinal preparation with Lactulose vs. Sodium Phosphate as the better agent for performing high-quality colonoscopies at the Civil Hospital Fray Antonio Alcalde and the Civil Hospital Juan I. Menchaca, both in Guadalajara, Mexico; as well as Hospital Santo Tomás in Panama City, Panama; and Hospital Gustavo Nelson Collado Ríos in Chitré, Panama; during the period from April 1, 2025, to November 30, 2025. The comparison will focus on colonoscopy quality, patient tolerance, satisfaction, and electrolyte changes, using the agents orally as part of the bowel preparation prior to the colonoscopy procedure.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07060222
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Hospital Civil de Guadalajara trials
Trials by the same sponsor.
- NCT07404345 — Low-Dose Apixaban Added to Standard Heparin Lock Versus Heparin Lock Alone to Prevent Tunneled Hemodialysis Catheters Dy · Phase 4 · not yet recruiting
- NCT07436130 — Curcumin in Critically Ill Patients With Sepsis · NA · not yet recruiting
- NCT07224997 — Trimethoprim-Sulfamethoxazole (TMP/SMX) Prophylaxis After Acute Kidney Injury to Prevent Post-discharge Infections · Phase 2 · not yet recruiting
- NCT07205627 — Evaluation of the Diaphragmatic Index Before and After a Pulmonary Rehabilitation Program in Patients With Interstitial · NA · not yet recruiting
- NCT07198750 — "Bimodal vs Unimodal High-Intensity Pulsed Electromagnetic Field Therapy in Older Adults With Knee Osteoarthritis" · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07060222 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hospital Civil de Guadalajara
- Last refreshed: 22 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07060222.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing